Key Segmentation
By Treatment Type
-
Gluten-Free Diet Management
-
Enzyme Replacement Therapy
-
Immunomodulators
-
Steroids & Vitamins/Minerals Supplementation
-
Others
By Route of Administration
-
Oral
-
Injectable
-
Others
By Drug Class
-
Biologics
-
Small Molecules
-
Nutritional Supplements
By End User
-
Hospitals & Specialty Clinics
-
Research Centers
-
Homecare Settings
By Distribution Channel
-
Hospital Pharmacies
-
Retail Pharmacies
-
Online Pharmacies
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
North America dominated the celiac disease treatment market in 2025.
Gluten-free diet management dominated the celiac disease treatment market with 48.74% share in 2025.
The primary growth factors are the expanding pharmaceutical pipeline for non-dietary treatment options and rising global celiac disease diagnosis rates driven by improved screening and genetic testing accessibility.
The celiac disease treatment market was valued at USD 0.82 Billion in 2025.
The celiac disease treatment market is expected to grow at a CAGR of 11.24% from 2026 to 2035.